Skip to main content

Table 1 Summary of fusion expression by RT-qPCR

From: Fusion transcript loci share many genomic features with non-fusion loci

  

(anti)-androgen regulationa

Tumor expressiona

Fusion transcript

Gene

DHT

BIC

ENZ

T/N

NOS1AP-c1orf226

Fusion

↓

↓

↓

-

 

NOS1AP

↓

↓

↓

-

 

c1orf226

↓

↓

↓

-

HARS-ZMAT2

Fusion

↓

-

-

-

 

HARS

↓

↓

↑

-

 

ZMAT2

↓

↓

-

↓

DHRS1-RABGGTA

Fusion

↑

↓

-

↓

 

DHRS1

-

-

-

-

 

RABGGTA

-

-

-

-

CTBS-GNG5

Fusion

↑

↑

↑

NE

 

CTBS

↑

↑

↑

-

 

GNG5

-

-

-

-

C17orf106-CDK3

Fusion

↑

↑

-

NE

 

C17orf106

↑

↑

↑

NE

 

CDK3

↑

↑

-

-

SIDT2-TAGLN

Fusion

↑

↑

↑

NE

 

SIDT2

↑

↑

↑

↓

 

TAGLN

↑

↑

↑

↓

C1QTNF3-AMACR

Fusion

↓

↓

↓

-

 

C1QTNF3

↓

-

-

-

 

AMACR

↑

-

-

↑

  1. aAt least two-fold higher- (↑), lower- (↓), or no change (-) in expression after (anti)-androgen treatment to mock treatments
  2. bAt least four of seven tumours with at least 2-fold over- (↑), under- (↓), or no change (-) in expression in tumors relative to non-tumor cells
  3. DHT dihydrotestosterone (androgen), BIC bicalutamide (anti-androgen), ENZ enzalutamide (anti-androgen), NE not expressed